The protein toxin from Pasteurella multocida (PMT) experimentally induces all of the major symptoms of a number of economically important zoonotic diseases in wild animals and domestic livestock and pets ( Foged 1992; Arashima and Kumasaka 2005; Harper et al. 2006; Wilson and Ho 2006), including moderate to severe progressive atrophic rhinitis, bite wound dermonecrosis and abscesses, chronic respiratory infection, and decreased overall stature and weight gain. PMT is a 1285-amino-acid protein that binds to and enters mammalian cells via receptor-mediated endocytosis ( Rozengurt et al. 1990; Pettit et al. 1993; Dudet et al. 1996). PMT has dramatic and differential effects on differentiation and proliferation of fibroblasts, bone cells, epithelial cells, and cardiomyocytes (for review, see Wilson and Ho 2004, 2006). In fibroblasts and osteoblasts, PMT acts intracellularly to enhance calcium signaling pathways, including inositol phospholipid hydrolysis, intracellular Ca 2+ mobilization, increased protein kinase C (PKC)-dependent phosphorylation, and calcineurin-dependent nuclear factor of activated T cells (NFAT) activation ( Staddon et al. 1990, 1991; Wilson et al. 1997; Sabri et al. 2002; Aminova and Wilson 2007; Luo et al. 2007), as well as mitogenic pathways, including increased tyrosine phosphorylation, MAPK (Erk1/2, p38) activation, and DNA synthesis ( Rozengurt et al. 1990; Dudet et al. 1996; Lacerda et al. 1996; Mullan and Lax 1996; Seo et al. 2000; Wilson et al. 2000). The primary intracellular target of PMT responsible for activation of the phospholipase C β1 (PLCβ1) pathway is the free, monomeric α subunit of the G q protein ( Wilson et al. 1997; Zywietz et al. 2001; Wilson and Ho 2004). PMT-induced stimulation of PLCβ1 by Gα q leads to the hydrolysis of phosphatidylinositol 4,5-bisphosphate to inositol 1,4,5-trisphosphate and diacylglycerol. Accordingly, the release of these second messengers stimulates Ca 2+ mobilization and activates PKC-dependent phosphorylation and calcineurin-dependent NFAT activation. PMT stimulation of mitogen-activated protein kinase occurs upstream via G q/11-dependent transactivation of the epidermal growth factor receptor ( Seo et al. 2000). PMT also initiates cytoskeletal rearrangements, including focal adhesion assembly and stress fiber development ( Dudet et al. 1996; Lacerda et al. 1996; Ohnishi et al. 1998). At least part of the mitogenic effect of PMT occurs through a G q-independent pathway ( Zywietz et al. 2001). Rho activation by PMT has been reported to be the result of indirect activation through G 12/13 ( Orth et al. 2005) or through tyrosine kinases ( Sagi et al. 2001). Our recent study revealed two additional pathways affected by PMT, namely, down-regulation of Notch1 and stabilization of β-catenin during adipocyte differentiation ( Aminova and Wilson 2007). There is now strong evidence that the G q-activating domain of PMT is localized to the C terminus, since site-specific mutations at H1205, H1223, and C1165 abolish intracellular activity when the mutant proteins are introduced into cells via microinjection ( Pullinger et al. 2001; Baldwin et al. 2004) or electroporation ( Busch et al. 2001; Orth et al. 2003). The recently reported crystal structure of the C-terminal 575–1285 residues revealed three subdomains (see Fig. 1), designated as C1, C2, and C3 domains ( Kitadokoro et al. 2007). The shortest active fragment in this study was identified as residues 569–1285. According to this study, the C1 domain (residues 575–719) may be responsible for membrane targeting, the C2 domain (residues 720–1104) has no obvious function, and the C3 domain (residues 1105–1285) possesses a putative Cys-His-Asp catalytic triad, which when the C1165 is released from a disulfide bond (C1159-C1165) through mutation of C1159 to Ser sterically aligns to that of a papain or cysteine protease-like triad. However, the authors were not able to demonstrate any proteolytic activity. | Figure 1.Structure of C-PMT. Shown is a ribbon diagram of the C terminus of PMT (C-PMT, residues 575–1285): C1 (blue, 575–719), C2 (green, 720–1104), and C3 (red, 1105–1285). Lines indicate location of the starting residue (yellow (more ...) |
The minimal domain of PMT responsible for intracellular activation of G q-dependent signaling has been the subject of some debate. One group reported that a C-terminal fragment of PMT consisting of residues 720–1285, when microinjected into cells, induced cellular morphology changes similar to full-length PMT, while a smaller fragment consisting of residues 849–1285 showed no activity ( Pullinger et al. 2001). Consistent with the shortest active fragment of 569–1285 reported in the crystallographic study ( Kitadokoro et al. 2007), another group found that a fragment of PMT consisting of residues 581–1285, when electroporated into cells, increased intracellular inositol phosphate levels, but a fragment consisting of residues 701–1285 was not biologically active ( Busch et al. 2001). However, none of these studies demonstrated intracellular activity in smaller fragments consisting of only the C3 domain. The methods used in previous studies to define the minimal intracellular activity domain relied on expression and purification of the recombinant truncated proteins from Escherichia coli, which assumed that these mutant proteins folded properly in E. coli without proteolytic degradation and were stable enough to withstand subsequent purification steps. In each study, the choice of truncation site was arbitrary and only a few relatively large truncation mutants were examined. In addition, these studies also assumed that the techniques used to introduce the truncated proteins into the cells (i.e., microinjection or electroporation) would not perturb the functional readout of the assay, such as cytoskeletal changes, calcium, or other signaling. |
References Aminova, L.R., Wilson, B.A. Calcineurin-independent inhibition of 3T3-L1 adipogenesis by Pasteurella multocida toxin: Suppression of Notch1, stabilization of β-catenin and pre-adipocyte factor 1. Cell. Microbiol. 2007;9:2485–2496. [PubMed]Arashima, Y., Kumasaka, K. Pasteurellosis as zoonosis. Intern. Med. 2005;44:692–693. [PubMed]Baldwin, M.R., Lakey, J.H., Lax, A.J. Identification and characterization of the Pasteurella multocida toxin translocation domain. Mol. Microbiol. 2004;54:239–250. [PubMed]Busch, C., Orth, J., Djouder, N., Aktories, K. Biological activity of a C-terminal fragment of Pasteurella multocida toxin. Infect. Immun. 2001;69:3628–3634. [PubMed]Crabtree, G.R., Olson, E.N. NFAT signaling: Choreographing the social lives of cells. Cell. 2002;109(Suppl):S67–S79. doi: 10.1016/S0092-8674(02)00699-2. [PubMed]Dudet, L.I., Chailler, P., Dubreuil, J.D., Martineau-Doize, B.
Pasteurella multocida toxin stimulates mitogenesis and cytoskeleton reorganization in Swiss 3T3 fibroblasts. J. Cell. Physiol. 1996;168:173–182. [PubMed]Foged, N.T.
Pasteurella multocida toxin. The characterisation of the toxin and its significance in the diagnosis and prevention of progressive atrophic rhinitis in pigs. APMIS Suppl. 1992;25:1–56. [PubMed]Fromm, C., Coso, O.A., Montaner, S., Xu, N., Gutkind, J.S. The small GTP-binding protein Rho links G protein-coupled receptors and Gα 12 to the serum response element and to cellular transformation. Proc. Natl. Acad. Sci. 1997;94:10098–10103. [PubMed]Harper, M., Boyce, J.D., Adler, B.
Pasteurella multocida pathogenesis: 125 years after Pasteur. FEMS Microbiol. Lett. 2006;265:1–10. [PubMed]Hill, C.S., Wynne, J., Treisman, R. The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell. 1995;81:1159–1170. [PubMed]Im, S.H., Rao, A. Activation and deactivation of gene expression by Ca 2+/calcineurin-NFAT-mediated signaling. Mol. Cells. 2004;18:1–9. [PubMed]Kitadokoro, K., Kamitani, S., Miyazawa, M., Hanajima-Ozawa, M., Fukui, A., Miyake, M., Horiguchi, Y. Crystal structures reveal a thiol protease-like catalytic triad in the C-terminal region of Pasteurella multocida toxin. Proc. Natl. Acad. Sci. 2007;104:5139–5144. [PubMed]Lacerda, H.M., Lax, A.J., Rozengurt, E.
Pasteurella multocida toxin, a potent intracellularly acting mitogen, induces p125FAK and paxillin tyrosine phosphorylation, actin stress fiber formation, and focal contact assembly in Swiss 3T3 cells. J. Biol. Chem. 1996;271:439–445. [PubMed]Luo, S., Ho, M., Wilson, B.A. Application of intact cell-based NFAT-β-lactamase reporter assay for Pasteurella multocida toxin-mediated activation of calcium signaling pathway. Toxicon. 2008;51:597–605. [PubMed]Mullan, P.B., Lax, A.J.
Pasteurella multocida toxin is a mitogen for bone cells in primary culture. Infect. Immun. 1996;64:959–965. [PubMed]Ohnishi, T., Horiguchi, Y., Masuda, M., Sugimoto, N., Matsuda, M.
Pasteurella multocida toxin and Bordetella bronchiseptica dermonecrotizing toxin elicit similar effects on cultured cells by different mechanisms. J. Vet. Med. Sci. 1998;60:301–305. [PubMed]Orth, J.H., Blocker, D., Aktories, K. His1205 and His1223 are essential for the activity of the mitogenic Pasteurella multocida toxin. Biochemistry. 2003;42:4971–4977. [PubMed]Orth, J.H., Lang, S., Taniguchi, M., Aktories, K.
Pasteurella multocida toxin-induced activation of RhoA is mediated via two families of Gα proteins, Gα q and Gα 12/13
. J. Biol. Chem. 2005;280:36701–36707. [PubMed]Pettit, R.K., Ackermann, M.R., Rimler, R.B. Receptor-mediated binding of Pasteurella multocida dermonecrotic toxin to canine osteosarcoma and monkey kidney (vero) cells. Lab. Invest. 1993;69:94–100. [PubMed]Pullinger, G.D., Sowdhamini, R., Lax, A.J. Localization of functional domains of the mitogenic toxin of Pasteurella multocida
. Infect. Immun. 2001;69:7839–7850. [PubMed]Rozengurt, E., Higgins, T., Chanter, N., Lax, A.J., Staddon, J.M.
Pasteurella multocida toxin: Potent mitogen for cultured fibroblasts. Proc. Natl. Acad. Sci. 1990;87:123–127. [PubMed]Sabri, A., Wilson, B.A., Steinberg, S.F. Dual actions of the Gα q agonist Pasteurella multocida toxin to promote cardiomyocyte hypertrophy and enhance apoptosis susceptibility. Circ. Res. 2002;90:850–857. [PubMed]Sagi, S.A., Seasholtz, T.M., Kobiashvili, M., Wilson, B.A., Toksoz, D., Brown, J.H. Physical and functional interactions of Gα q with Rho and its exchange factors. J. Biol. Chem. 2001;276:15445–15452. [PubMed]Seo, B., Choy, E.W., Maudsley, S., Miller, W.E., Wilson, B.A., Luttrell, L.M.
Pasteurella multocida toxin stimulates mitogen-activated protein kinase via G q/11-dependent transactivation of the epidermal growth factor receptor. J. Biol. Chem. 2000;275:2239–2245. [PubMed]Staddon, J.M., Chanter, N., Lax, A.J., Higgins, T.E., Rozengurt, E.
Pasteurella multocida toxin, a potent mitogen, stimulates protein kinase C-dependent and -independent protein phosphorylation in Swiss 3T3 cells. J. Biol. Chem. 1990;265:11841–11848. [PubMed]Staddon, J.M., Barker, C.J., Murphy, A.C., Chanter, N., Lax, A.J., Michell, R.H., Rozengurt, E.
Pasteurella multocida toxin, a potent mitogen, increases inositol 1,4,5-trisphosphate and mobilizes Ca 2+ in Swiss 3T3 cells. J. Biol. Chem. 1991;266:4840–4847. [PubMed]Ward, P.N., Miles, A.J., Sumner, I.G., Thomas, L.H., Lax, A.J. Activity of the mitogenic Pasteurella multocida toxin requires an essential C-terminal residue. Infect. Immun. 1998;66:5636–5642. [PubMed]Wilson, B.A., Ho, M.
Pasteurella multocida toxin as a tool for studying G q signal transduction. Rev. Physiol. Biochem. Pharmacol. 2004;152:93–109. [PubMed]Wilson, B.A., Ho, M.
Pasteurella multocida toxin. In: Alouf J.E., Popoff M.R., editors. The comprehensive sourcebook of bacterial protein toxins. 3rd ed. Academic Press; Boston, MA: 2006. pp. 430–447. Wilson, B.A., Zhu, X., Ho, M., Lu, L.
Pasteurella multocida toxin activates the inositol triphosphate signaling pathway in Xenopus oocytes via G qα-coupled phospholipase C-β1. J. Biol. Chem. 1997;272:1268–1275. [PubMed]Wilson, B.A., Ponferrada, V.G., Vallance, J.E., Ho, M. Localization of the intracellular activity domain of Pasteurella multocida toxin to the N terminus. Infect. Immun. 1999;67:80–87. [PubMed]Wilson, B.A., Aminova, L.R., Ponferrada, V.G., Ho, M. Differential modulation and subsequent blockade of mitogenic signaling and cell cycle progression by Pasteurella multocida toxin. Infect. Immun. 2000;68:4531–4538. [PubMed]Zywietz, A., Gohla, A., Schmelz, M., Schultz, G., Offermanns, S. Pleiotropic effects of Pasteurella multocida toxin are mediated by G q-dependent and -independent mechanisms. Involvement of G q but not G 11
. J. Biol. Chem. 2001;276:3840–3845. [PubMed]
|